Adjuvant perioperative portal vein or peripheral intravenous chemotherapy for potentially curative colorectal cancer: Long-term results of a randomized controlled trial

International Journal of Colorectal Disease

Volumn 23, Issue 12, 2008, Pages 1233-1241

  Laffer, U ^a   Metzger, U ^a   Aeberhard, P ^a   Lorenz, M ^a   Harder, F ^a   Maibach, R ^a   Zuber, M ^a   Herrmann, Richard ^a  

^a SWISS GROUP FOR CLINICAL CANCER RESEARCH SAKK   (Switzerland)

Author keywords

Adjuvant chemotherapy; Colorectal cancer; Portal infusion

Indexed keywords

FLUOROURACIL; HEPARIN; MITOMYCIN C;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG INFUSION; DRUG WITHDRAWAL; FEMALE; HUMAN; LEUKOCYTE COUNT; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OVERALL SURVIVAL; PORTAL VEIN; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; THROMBOCYTE COUNT;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; PORTAL VEIN; PROSPECTIVE STUDIES;

EID: 56749152432     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-008-0543-8     Document Type: Article

References (22)

1. Pisani P, Parkin DM, Ferlay J (1993) Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 55(6):891-903
2. Oldham U (1985) Colorectal Carcinoma: A survey of 1345 cases 1950-1984. Acta Chir Scand 151:675-679
3. Buyse M, Zeleniuch-Jacquotte A, Chalmers TC (1988) Adjuvant therapy of colorectal cancer. Why we still don't know. J Am Med Assoc 259(24):3571-3578
4. Morales F, Bell M, McDonald GO, Cole WH (1957) The prophylactic treatment of cancer at the time of operation. Ann Surg 146(4):588-593 discussion 593-5
5. Taylor I, Rowling J, West C (1979) Adjuvant cytotoxic liver perfusion for colorectal cancer. Br J Surg 66(12):833-837
6. Swiss Group for Clinical Cancer Research (SAKK) (1995) Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Lancet 345(8946):349-353
7. Patt YZ, Mavligit GM, Chuang VP, Wallace S, Johnston S, Benjamin RS et al (1980) Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): An effective treatment for metastatic colorectal carcinoma in the liver. Cancer 46(2):261-265
8. Beart RW Jr., Moertel CG, Wieand HS, Leigh JE, Windschitl HE, van Heerden JA et al (1990) Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and the North Central Cancer Treatment Group. Arch Surg 125(7):897-901
9. Fielding LP, Hittinger R, Grace RH, Fry JS (1992) Randomised controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma. Lancet 340(8818):502-506
10. Wereldsma JC, Bruggink ED, Meijer WS, Roukema JA, van Putten WL (1990) Adjuvant portal liver infusion in colorectal cancer with 5-fluorouracil/ heparin versus urokinase versus control. Results of a prospective randomized clinical trial (colorectal adenocarcinoma trial I). Cancer 65(3):425-432
11. Taylor I, Machin D, Mullee M, Trotter G, Cooke T, West C (1985) A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. Br J Surg 72(5):359-363
12. Liver Infusion Meta-analysis Group (1997) Portal vein chemotherapy for colorectal cancer: A meta-analysis of 4000 patients in 10 studies. J Natl Cancer Inst 89(7):497-505
13. Rougier P, Sahmoud T, Nitti D, Curran D, Doci R, De Waele B et al (1998) Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: A randomised trial. European Organisation for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group, the Gruppo Interdisciplinare Valutazione Interventi in Oncologia, and the Japanese Foundation for Cancer Research. Lancet 351(9117):1677-1681
14. Arnaud JP, Buyse M, Nordlinger B, Martin F, Pector JC, Zeitoun P et al (1989) Adjuvant therapy of poor prognosis colon cancer with levamisole: results of an EORTC double-blind randomized clinical trial. Br J Surg 76(3):284-289
15. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen CM, Ungerleider JS, Emerson WA, Tormey DC, Glick JC et al (1995) Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/ Dukes' B2 colon cancer. J Clin Oncol 13(12):2936-2943
16. Francini G, Petrioli R, Lorenzini L, Mancini S, Armenio S, Tanzini G, Marsili S, Aquino A, Marzocca G, Civitelli S et al (1994) Kolonic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. Gastroenerol 106(4):899-906
17. Schumacher K (2000) Comparison of fluorouracil + folonic acid, fluorouracil + levamisole and fluorouracil + folonic acid + levamisole in Dukes' B and C colon cancer: NSABP Trial C-04. Strahlenther Onkol 176(5):239-240
18. Haller GD, Catalano PJ, Macdonald JS, O'Rourke MA, Fronziera MS, Jackson DV, Mayer RJ (2005) Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: Final report of Intergroup 0089. J Clin Oncol 23(34):8671-8678
19. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK (1998) Rectal cancer: The Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 133(8):894-899
20. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R, German Rectal Cancer Study Group (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351(17):1731-1740
21. O'Connell MJ, Laurie JA, Kahn M, Fitzgibbons RJ Jr, Erlichman C, Shepherd L, Moertel CG, Kocha WI, Pazdur R, Wieand HS, Rubin J, Vukov AM, Donohue JH, Krook JE, Figueredo A (1998) Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol 16(1):295-300
22. André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, Tabah-Fisch I, de Gramont A (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators N Engl J Med 350(23):2343-2351